The loss of SETD2 activates the BMP2 signaling pathway, driving CAFs to adopt a lipid‐rich phenotype that supports tumor cell growth through lipid transfer, thus promoting pancreatic cancer progression [143]. The gene discussed is SETD2; the disease is pancreatic neoplasm.